Redhill Biopharma Ltd.

Redhill Biopharma Ltd. company information, Employees & Contact Information

Explore related pages

Redhill Biopharma Ltd. email format Redhill Biopharma Ltd. management contacts

Related company profiles:

RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on gastrointestinal diseases and infectious diseases. RedHill’s U.S. commercial operations, headquartered in Raleigh, NC, include a gastrointestinal-focused sales force promoting several specialty gastrointestinal products in the U.S. RedHill’s pipeline includes several drug candidates in advanced clinical development stages addressing clear medical needs and aiming to relieve suffering and save lives. RedHill’s drugs are largely de-risked and are potentially of lower cost and faster to market than new chemical entities under development. RedHill’s products are based on several technology platforms and address several disease targets, thus providing for risk diversification. RedHill’s experienced management team, board of directors and advisory board, based in Israel, the U.S., Canada and Europe, comes with a successful track record of bringing patented drugs to the market, as well as extensive managerial, financial, and transactional expertise.

Company Details

Employees
48
Founded
-
Address
8045 Arco Corporate Drive, Suite 120,israel
Phone
+972 3-541-3131
Email
in****@****bio.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
redhillbio.com
Keywords
Engineer jobs.
HQ
Raleigh, NC
Competitors
Ironshore, Vertex Pharmaceuticals, Madrigal Pharmaceuticals, Collegium Pharmaceutical, Inc., Biogen, Purple Biotech, AbbVie, FibroGen, Inc., Jnana Therapeutics.
Looking for a particular Redhill Biopharma Ltd. employee's phone or email?

Redhill Biopharma Ltd. Questions

News

RedHill Licenses RHB-102 for Commercialization Worldwide Excluding North America to Hyloris for up to $60 Million in Potential Milestone Payments Plus Royalties - PR Newswire

RedHill Licenses RHB-102 for Commercialization Worldwide Excluding North America to Hyloris for up to $60 Million in Potential Milestone Payments Plus Royalties PR Newswire

RedHill Receives Positive FDA Feedback on Pathway to Approval of Groundbreaking RHB-204 for Crohn's Disease - Yahoo Finance

RedHill Receives Positive FDA Feedback on Pathway to Approval of Groundbreaking RHB-204 for Crohn's Disease Yahoo Finance

Early treatment with upamostat reduces COVID-19 symptoms, hospitalizations - Healio

Early treatment with upamostat reduces COVID-19 symptoms, hospitalizations Healio

RedHill Biopharma Announces Positive Top-Line Results from Phase II Study of BEKINDA® in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) - European Medical Journal

RedHill Biopharma Announces Positive Top-Line Results from Phase II Study of BEKINDA® in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) European Medical Journal

Talicia Gets FDA Approval for H. pylori Treatment - Medical Professionals Reference

Talicia Gets FDA Approval for H. pylori Treatment Medical Professionals Reference

RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights - PR Newswire

RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights PR Newswire

RedHill Biopharma to Host Fourth Quarter and Full-Year 2017 Financial Results Conference Call on February 22, 2018 - GlobeNewswire

RedHill Biopharma to Host Fourth Quarter and Full-Year 2017 Financial Results Conference Call on February 22, 2018 GlobeNewswire

RedHill Biopharma Receives Nasdaq Staff Determination Notification - The Malaysian Reserve

RedHill Biopharma Receives Nasdaq Staff Determination Notification The Malaysian Reserve

Three-Drug Combo Talicia Now Available for H. pylori Infection - Medical Professionals Reference

Three-Drug Combo Talicia Now Available for H. pylori Infection Medical Professionals Reference

RedHill Biopharma Advances its Groundbreaking Late-Stage Crohn's Disease Program Building on Statistically Significant Positive RHB-104 Phase 3 Results - PR Newswire

RedHill Biopharma Advances its Groundbreaking Late-Stage Crohn's Disease Program Building on Statistically Significant Positive RHB-104 Phase 3 Results PR Newswire

RedHill Biopharma and South Korea's Kukbo Co. Announce a Strategic Investment of Up To $10 Million in RedHill - PR Newswire

RedHill Biopharma and South Korea's Kukbo Co. Announce a Strategic Investment of Up To $10 Million in RedHill PR Newswire

Companies like Redhill Biopharma Ltd.

Purple Biotech logo - Similar company to Redhill Biopharma Ltd.

Purple Biotech

11
Madrigal Pharmaceuticals logo - Similar company to Redhill Biopharma Ltd.

Madrigal Pharmaceuti...

755
Collegium Pharmaceutical, Inc. logo - Similar company to Redhill Biopharma Ltd.

Collegium Pharmaceut...

413
Ironshore logo - Similar company to Redhill Biopharma Ltd.

Ironshore

68
Vertex Pharmaceuticals logo - Similar company to Redhill Biopharma Ltd.

Vertex Pharmaceuticals

6.09K
Biogen logo - Similar company to Redhill Biopharma Ltd.

Biogen

7.60K
FibroGen, Inc. logo - Similar company to Redhill Biopharma Ltd.

Fibrogen, Inc.

300
Jnana Therapeutics logo - Similar company to Redhill Biopharma Ltd.

Jnana Therapeutics

93
AbbVie logo - Similar company to Redhill Biopharma Ltd.

Abbvie

57.01K

Top Redhill Biopharma Ltd. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant